Unknown

Dataset Information

0

Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia.


ABSTRACT: Background:Serum hemeoxygenase-1 (HO-1) has been proposed to be a biomarker of lung disease activity and prognosis. The present study aimed at evaluating whether HO-1 could be a useful marker for evaluating disease activity and predicting prognosis in patients with interstitial pneumonia (IP). Materials and Methods:Serum HO-1 levels of newly diagnosed or untreated patients with IP were measured at hospitalization. We evaluated the relationships between serum HO-1 and other serum biomarkers, high resolution CT (HRCT) findings, and hospital mortality. Results:Twenty-eight patients with IP, including 14 having an acute exacerbation (AE) and 14 not having an AE, were evaluated. The patients having an AE had significantly higher HO-1 levels than those not having an AE (53.5?ng/mL vs. 24.1?ng/mL; p < 0.001), and the best cut-off level to discriminate between having an AE or not having an AE was 41.6?ng/mL. Serum HO-1 levels were positively correlated with serum levels of surfactant protein-D (r=0.66, p < 0.001) and the ground glass opacity score (calculated from HRCT; r=0.40, p=0.036). Patients who subsequently died in hospital had presented with significantly higher HO-1 levels than those who did not die in hospital (64.8?ng/mL vs. 32.0?ng/mL; p=0.009). Conclusion:Serum HO-1 may serve as a useful biomarker for detecting AE or predicting hospital mortality in patients with IP.

SUBMITTER: Murohashi K 

PROVIDER: S-EPMC6282126 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical Significance of Serum Hemeoxygenase-1 as a New Biomarker for the Patients with Interstitial Pneumonia.

Murohashi Kota K   Hara Yu Y   Shinada Kanako K   Nagai Kenjiro K   Shinkai Masaharu M   Kawana Akihiko A   Kaneko Takeshi T  

Canadian respiratory journal 20181122


<h4>Background</h4>Serum hemeoxygenase-1 (HO-1) has been proposed to be a biomarker of lung disease activity and prognosis. The present study aimed at evaluating whether HO-1 could be a useful marker for evaluating disease activity and predicting prognosis in patients with interstitial pneumonia (IP).<h4>Materials and methods</h4>Serum HO-1 levels of newly diagnosed or untreated patients with IP were measured at hospitalization. We evaluated the relationships between serum HO-1 and other serum b  ...[more]

Similar Datasets

| S-EPMC3653086 | biostudies-other
| S-EPMC6506377 | biostudies-literature
| S-EPMC4356040 | biostudies-literature
| S-EPMC4462361 | biostudies-literature
| S-EPMC6819570 | biostudies-literature
| S-EPMC3598392 | biostudies-literature
| S-EPMC2718398 | biostudies-literature
| S-EPMC6957301 | biostudies-literature
| S-EPMC3852842 | biostudies-literature
| S-EPMC6316687 | biostudies-literature